Feature|Articles|February 15, 2024
- Pharmaceutical Executive: February 2024
- Volume 44
- Issue 1
Pharmaceutical Executive: February 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 2 years ago
Central to the Missionabout 2 years ago
Two Frameworks for Orphan Drug IDN Launch Planningabout 2 years ago
Sustainability and Progress Continue to Make Headlines in 2024about 2 years ago
Building Resiliency: Essential Leadership Principles for 2024about 2 years ago
Will Strong Early-Year Vibes Translate to More Stabilization Ahead?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
2
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
3
Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers
4
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
5